1374 related articles for article (PubMed ID: 9593664)
21. PTEN and myotubularin: novel phosphoinositide phosphatases.
Maehama T; Taylor GS; Dixon JE
Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
[TBL] [Abstract][Full Text] [Related]
22. AKT1 and PTEN show the highest affinities among phosphoinositide binding proteins for the second messengers PtdIns(3,4,5)P
Nelson N; Razeto A; Gilardi A; Grättinger M; Kirchmair J; Jücker M
Biochem Biophys Res Commun; 2021 Sep; 568():110-115. PubMed ID: 34214875
[TBL] [Abstract][Full Text] [Related]
23. Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN.
Mandl A; Sarkes D; Carricaburu V; Jung V; Rameh L
Mol Cell Biol; 2007 Dec; 27(23):8098-112. PubMed ID: 17893321
[TBL] [Abstract][Full Text] [Related]
24. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes.
Tang X; Powelka AM; Soriano NA; Czech MP; Guilherme A
J Biol Chem; 2005 Jun; 280(23):22523-9. PubMed ID: 15824124
[TBL] [Abstract][Full Text] [Related]
25. Localization of agonist-sensitive PtdIns(3,4,5)P3 reveals a nuclear pool that is insensitive to PTEN expression.
Lindsay Y; McCoull D; Davidson L; Leslie NR; Fairservice A; Gray A; Lucocq J; Downes CP
J Cell Sci; 2006 Dec; 119(Pt 24):5160-8. PubMed ID: 17158918
[TBL] [Abstract][Full Text] [Related]
26. Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN.
Rouault JP; Kuwabara PE; Sinilnikova OM; Duret L; Thierry-Mieg D; Billaud M
Curr Biol; 1999 Mar; 9(6):329-32. PubMed ID: 10209098
[TBL] [Abstract][Full Text] [Related]
27. Phosphoinositide lipid phosphatase SHIP1 and PTEN coordinate to regulate cell migration and adhesion.
Mondal S; Subramanian KK; Sakai J; Bajrami B; Luo HR
Mol Biol Cell; 2012 Apr; 23(7):1219-30. PubMed ID: 22323291
[TBL] [Abstract][Full Text] [Related]
28. Regulation of PtdIns(3,4,5)P3/Akt signalling by inositol polyphosphate 5-phosphatases.
Eramo MJ; Mitchell CA
Biochem Soc Trans; 2016 Feb; 44(1):240-52. PubMed ID: 26862211
[TBL] [Abstract][Full Text] [Related]
29. The INPP4B paradox: Like PTEN, but different.
Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA
Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856
[TBL] [Abstract][Full Text] [Related]
30. Lipid phosphatases in the regulation of T cell activation: living up to their PTEN-tial.
Seminario MC; Wange RL
Immunol Rev; 2003 Apr; 192():80-97. PubMed ID: 12670397
[TBL] [Abstract][Full Text] [Related]
31. In vivo analysis of 3-phosphoinositide dynamics during Dictyostelium phagocytosis and chemotaxis.
Dormann D; Weijer G; Dowler S; Weijer CJ
J Cell Sci; 2004 Dec; 117(Pt 26):6497-509. PubMed ID: 15572406
[TBL] [Abstract][Full Text] [Related]
32. Expanding coincident signaling by PTEN through its inositol 1,3,4,5,6-pentakisphosphate 3-phosphatase activity.
Caffrey JJ; Darden T; Wenk MR; Shears SB
FEBS Lett; 2001 Jun; 499(1-2):6-10. PubMed ID: 11418101
[TBL] [Abstract][Full Text] [Related]
33. The inositol polyphosphate 5-phosphatase, PIPP, Is a novel regulator of phosphoinositide 3-kinase-dependent neurite elongation.
Ooms LM; Fedele CG; Astle MV; Ivetac I; Cheung V; Pearson RB; Layton MJ; Forrai A; Nandurkar HH; Mitchell CA
Mol Biol Cell; 2006 Feb; 17(2):607-22. PubMed ID: 16280363
[TBL] [Abstract][Full Text] [Related]
34. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.
Lu Y; Yu Q; Liu JH; Zhang J; Wang H; Koul D; McMurray JS; Fang X; Yung WK; Siminovitch KA; Mills GB
J Biol Chem; 2003 Oct; 278(41):40057-66. PubMed ID: 12869565
[TBL] [Abstract][Full Text] [Related]
35. Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1.
Nishio M; Watanabe K; Sasaki J; Taya C; Takasuga S; Iizuka R; Balla T; Yamazaki M; Watanabe H; Itoh R; Kuroda S; Horie Y; Förster I; Mak TW; Yonekawa H; Penninger JM; Kanaho Y; Suzuki A; Sasaki T
Nat Cell Biol; 2007 Jan; 9(1):36-44. PubMed ID: 17173042
[TBL] [Abstract][Full Text] [Related]
36. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.
Stambolic V; Suzuki A; de la Pompa JL; Brothers GM; Mirtsos C; Sasaki T; Ruland J; Penninger JM; Siderovski DP; Mak TW
Cell; 1998 Oct; 95(1):29-39. PubMed ID: 9778245
[TBL] [Abstract][Full Text] [Related]
37. A novel, rapid, and highly sensitive mass assay for phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) and its application to measure insulin-stimulated PtdIns(3,4,5)P3 production in rat skeletal muscle in vivo.
van der Kaay J; Batty IH; Cross DA; Watt PW; Downes CP
J Biol Chem; 1997 Feb; 272(9):5477-81. PubMed ID: 9038150
[TBL] [Abstract][Full Text] [Related]
38. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC.
Haas-Kogan D; Shalev N; Wong M; Mills G; Yount G; Stokoe D
Curr Biol; 1998 Oct; 8(21):1195-8. PubMed ID: 9799739
[TBL] [Abstract][Full Text] [Related]
39. The complexity of PTEN: mutation, marker and potential target for therapeutic intervention.
Steelman LS; Bertrand FE; McCubrey JA
Expert Opin Ther Targets; 2004 Dec; 8(6):537-50. PubMed ID: 15584861
[TBL] [Abstract][Full Text] [Related]
40. The PTEN and Myotubularin phosphoinositide 3-phosphatases: linking lipid signalling to human disease.
Davies EM; Sheffield DA; Tibarewal P; Fedele CG; Mitchell CA; Leslie NR
Subcell Biochem; 2012; 58():281-336. PubMed ID: 22403079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
